CDK5 and cancer: Recently, Sharma et al. have utilised the melanoma cells expressing analogue-sensitive CDK5, which made it possible to specifically inhibit CDK5 in cancer cells, clearly demonstrating that inhibition of CDK5 in melanoma cells inhibits the metastatic spread of melanoma [194].